BioHarvest Sciences Inc. Common Stock (BHST)
Vancouver, BC, CA
BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.87% | +1.22% | -2.58% | -12.79% | -42.46% | -19.85% | -36.97% | -16.80% | -16.80% | -16.80% | -16.80% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
10.00
+243.6%
|
| Last Year | 1 |
10.00
+243.6%
|
| All Time | 3 |
12.33
+323.7%
|
-
Revenue growth Agricultural Inputs: +9.5%+37.0% ★ Q1'26: +8.2% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+25.0% ★ Q1'26: +7.7% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%-37.9% Q1'26: -25.5% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%-24.2% Q1'26: -21.6% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%-50.4% Q1'26: -36.2% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+13.7% Q1'26: +30.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×-2.10× Q1'26: -2.92× (vs Q1'25)
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
25.19M
est: 25.15M (+0.2%)
|
34.51M
est: 34.68M (-0.5%)
|
44.55M
43.73M – 45.36M
+28.4% YoY
|
60.50M
59.76M – 61.25M
+35.8% YoY
|
98.10M
93.49M – 102.18M
+62.1% YoY
|
132.48M
126.26M – 138.00M
+35.1% YoY
|
173.79M
165.63M – 181.03M
+31.2% YoY
|
| EBITDA |
-9.72M
est: -16.85M (+42.3%)
|
-6.71M
est: -23.24M (+71.1%)
|
-29.85M
-30.40M – -29.31M
-28.4% YoY
|
-40.55M
-41.05M – -40.05M
-35.8% YoY
|
-65.74M
-68.48M – -62.66M
-62.1% YoY
|
-88.79M
-92.49M – -84.62M
-35.1% YoY
|
-116.47M
-121.32M – -111.00M
-31.2% YoY
|
| EBIT |
-10.98M
est: -17.67M (+37.9%)
|
-8.34M
est: -24.37M (+65.8%)
|
-31.31M
-31.88M – -30.73M
-28.4% YoY
|
-42.52M
-43.04M – -42.00M
-35.8% YoY
|
-68.94M
-71.81M – -65.70M
-62.1% YoY
|
-93.11M
-96.99M – -88.74M
-35.1% YoY
|
-122.14M
-127.23M – -116.40M
-31.2% YoY
|
| Net Income |
-12.91M
est: -14.36M (+10.1%)
|
-11.14M
est: -11.37M (+2.1%)
|
-5.98M
-7.69M – -4.27M
+47.4% YoY
|
-1.56M
-4.30M – 1.56M
+73.8% YoY
|
8.10M
7.61M – 8.54M
+617.6% YoY
|
14.54M
13.66M – 15.33M
+79.5% YoY
|
23.75M
22.30M – 25.04M
+63.3% YoY
|
| SGA |
15.74M
est: 30.67M (-48.7%)
|
19.14M
est: 42.29M (-54.7%)
|
54.32M
53.33M – 55.32M
+28.4% YoY
|
73.78M
72.88M – 74.69M
+35.8% YoY
|
119.62M
114.01M – 124.61M
+62.1% YoY
|
161.56M
153.97M – 168.29M
+35.1% YoY
|
211.93M
201.98M – 220.76M
+31.2% YoY
|
| EPS |
-0.80
est: -0.78 (-2.6%)
|
-0.60
est: -0.62 (+2.8%)
|
-0.33
-0.42 – -0.23
+47.4% YoY
|
-0.09
-0.23 – 0.09
+73.8% YoY
|
0.44
0.41 – 0.46
+617.6% YoY
|
0.79
0.74 – 0.83
+79.5% YoY
|
1.29
1.21 – 1.36
+63.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | THOMPSON SIEGEL & WALMSLEY LLC | 386.8K +12.0K (+3.2%) | 1.68M -266.0K (-13.7%) | 2.10% +0.065 pp | 0.03% -0.003 pp | USD5.16 -15.9% | 2 qtrs — |
| 2 | TRUE NORTH ADVISORS, LLC | 168.0K +133.1K (+381.0%) | 729.2K +547.9K (+302.2%) | 0.91% +0.723 pp | 0.08% +0.060 pp | USD5.31 -18.3% | 6 qtrs — |
| 3 | MAGNUS FINANCIAL GROUP LLC | 55.0K +— (+0.0%) | 238.7K -46.8K (-16.4%) | 0.30% +0.000 pp | 0.02% -0.002 pp | USD6.19 -29.9% | 6 qtrs — |
| 4 | KING LUTHER CAPITAL MANAGEMENT CORP | 40.0K +— (+0.0%) | 173.6K -34.0K (-16.4%) | 0.22% +0.000 pp | 0.00% 0.000 pp | USD5.19 -16.4% | 2 qtrs — |
| 5 | SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC | 26.1K +26.1K (+100.0%) | 113.3K +113.3K (+100.0%) | 0.14% +0.142 pp | 0.06% +0.062 pp | USD4.34 +0.0% | 1 qtrs NEW |
| 6 | TD WATERHOUSE CANADA INC. | 23.8K +11.8K (+97.9%) | 101.7K +40.9K (+67.3%) | 0.13% +0.064 pp | 0.00% 0.000 pp | USD5.27 -17.6% | 6 qtrs — |
| 7 | JANE STREET GROUP, LLC | 13.1K -14.9K (-53.3%) | 56.8K -88.5K (-60.9%) | 0.07% -0.081 pp | 0.00% +0.000 pp | USD5.19 -16.4% | 2 qtrs — |
| 8 | UBS GROUP AG | 629.00 -544.0 (-46.4%) | 2.7K -3.4K (-55.2%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD5.19 -16.4% | 2 qtrs — |
| 9 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 76.00 +— (+0.0%) | 325.00 -60.0 (-15.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.17 -29.7% | 6 qtrs — |
| 10 | HRT FINANCIAL LP | — -14.6K (-100.0%) | — -75.0K (-100.0%) | 0.00% -0.080 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 11 | VIRTU FINANCIAL LLC | — -11.6K (-100.0%) | — -60.0K (-100.0%) | 0.00% -0.063 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Zaki Rakib | Co-Founder, CEO, Executive Chairman & President | 964.8K | — |
| Ilan Sobel | Chief Executive Officer | 470.2K | male |
| Yoheved Hagay | Co-Founder, Chief Technology Officer & Member of Scientific Advisory Board | 316.2K | — |
| Ilana Belzer | Chief Operating Officer | 302.0K | — |
| David K. Ryan | Vice President of Investor Relations & Secretary | 74.5K | male |
| Jared Turner | Vice President of D2C Products Business Unit | — | — |
| Bar Dichter | Chief Financial Officer | — | female |
| Malkit Azachi | Vice President of Research & Development | — | — |
| Michal Abargel Sapir | Vice President of Regulatory Affairs | — | female |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BHST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
